On January 9, 2019, the American Telemedicine Association (ATA) issued a policy comment letter to the U.S. Drug Enforcement Administration (DEA), advocating for provider-friendly changes to federal controlled substance prescribing rules. Note: the firm’s Telemedicine & Digital Health Industry Team participated in the ATA’s special workgroup to develop the recommendations.… Continue reading this entry
Tags: American Telemedicine Association, ATA, DEA, Ryan Haight Act, SUPPORT
President Trump just signed into law the “Special Registration for Telemedicine Act of 2018” (the Act), requiring the Drug Enforcement Administration (DEA) to activate a special registration allowing physicians and nurse practitioners to prescribe controlled substances via telemedicine without an in-person exam. The DEA has no more than one year to complete the task.… Continue reading this entry
Tags: controlled substances, DEA, Patients and Communities, prescriptions, Ryan Haight Act, Special Registration for Telemedicine Act, SUPPORT, Trump
Congress has taken another step forward to require the federal Drug Enforcement Administration (DEA) to activate a special registration allowing physicians and nurse practitioners to prescribe controlled substances via telemedicine without an in-person exam. The House Energy and Commerce Health subcommittee approved the Special Registration for Telemedicine Clarification Act of 2018, part of a larger … Continue reading this entry
Tags: controlled substances, DEA, prescriptions, Telemedicine
Editor’s Note: This article is the first of a series addressing telemedicine prescribing and controlled substances, designed to give some much needed practical guidance and orientation to established health care providers, hospitals, and entrepreneurs alike. As providers become more comfortable with delivering care via telemedicine, telehealth, and digital health technologies, some are exploring services beyond … Continue reading this entry
Tags: controlled substances, DEA, Prescribing medicine, prescription drugs, prescriptions, Ryan Haight, Ryan Haight Act, Telehealth, Telemedicine
Health care providers who use telemedicine for remote prescribing of controlled substances should pay close attention to an important case currently pending at the Fifth Circuit Court of Appeals. The case will decide whether or not the Drug Enforcement Administration can use administrative subpoenas to obtain and review medical records without a warrant to determine … Continue reading this entry
Tags: Controlled Substances Act, DEA, Ryan Haight Act, Telehealth, Texas
Posted in Policy; Telemedicine & Digital Health
Posted in Telemedicine & Digital Health